SPECT/CT in the Diagnosis of Dementia
NCT01112501 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82
Last updated 2010-04-28
Summary
Aim of the study is to evaluate whether Tc-99m-ECD-SPECT/CT enhances early diagnosis of dementia in two specific patient groups: (1) patient with mild cognitive impairment, and (2) patient with possible symptoms and signs of frontotemporal dementia. Evaluation of SPECT/CT data is performed both by visual and quantitative voxel-based analyses (Statistical Parametric Mapping). The final diagnosis is based on up to four years clinical follow-up.
Conditions
Sponsors & Collaborators
-
University of Eastern Finland
collaborator OTHER -
Kuopio University Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-09-30
- Primary Completion
- 2010-01-31
- Completion
- 2010-01-31
Countries
- Finland
Study Locations
More Related Trials
-
Metabolic Characterization of Alzheimer's Disease and Frontotemporal Dementia by 23Na-MRI and FDG-PET
NCT07100470 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
NCT00870519 ·Status: TERMINATED ·Phase: PHASE1
-
Isotopic Imaging for Prodromal Alzheimer's Disease
NCT01231295 ·Status: COMPLETED
-
Imaging Tau in Alzheimer's Disease and Normal Aging
NCT03373604 ·Status: COMPLETED ·Phase: PHASE2
-
Multimodal Imaging in the Study of Disorientation in the Hospital
NCT04387357 ·Status: UNKNOWN
-
University of Washington Alzheimer's Disease Research Center (UW ADRC) Imaging & Biomarker Core
NCT04437290 ·Status: UNKNOWN
-
Positron Emission Tomography of Amyloid in Alzheimer's Disease
NCT00205621 ·Status: SUSPENDED ·Phase: PHASE1
-
Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects
NCT04141150 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects
NCT02103894 ·Status: COMPLETED ·Phase: PHASE1
-
Memory Imaging of Normal Aging
NCT00315575 ·Status: COMPLETED
-
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
NCT05456503 ·Status: RECRUITING ·Phase: PHASE3
-
Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
NCT06254469 ·Status: RECRUITING ·Phase: PHASE3
-
Tau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases
NCT05260151 ·Status: UNKNOWN
-
Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment
NCT06965816 ·Status: COMPLETED
-
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
NCT03372317 ·Status: RECRUITING
-
Brain Iron Toxicity and Neurodegeneration - A 7T MRI Study
NCT04992975 ·Status: RECRUITING
-
Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion
NCT02353884 ·Status: COMPLETED
-
Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558
NCT01217021 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder
NCT00029120 ·Status: COMPLETED
-
Tau PET/CT in Various Tau-Related Disease Patients
NCT06690983 ·Status: RECRUITING
-
UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy
NCT03809351 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of Alteration by Magnetic Resonance Imaging (MRI) in Dementia Among Elderly Subjects
NCT00951197 ·Status: COMPLETED
-
Study of the Indications for Amyloid Positon Emission Tomography (PET) Scans and Their Usefulness for Patients With Suspected Alzheimer's Disease (AD)
NCT06467981 ·Status: COMPLETED
-
PET Study With 11 C-PIB to Evaluate Amyloid Protein Deposits in Mild Cognitive Disorder, Alzheimer's Disease and Early Frontotemporal Degeneration.
NCT06179979 ·Status: COMPLETED
-
Aβ PET and Tau PET Imaging in the Diagnosis and Progression Assessment of Alzheimer's Disease
NCT07114224 ·Status: NOT_YET_RECRUITING ·Phase: NA